Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 1.06
HNSN's Cash to Debt is ranked higher than
70% of the 291 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.06 vs. HNSN: 1.06 )
HNSN' s 10-Year Cash to Debt Range
Min: 0.4   Max: No Debt
Current: 1.06

Equity to Asset 0.30
HNSN's Equity to Asset is ranked higher than
53% of the 286 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.57 vs. HNSN: 0.30 )
HNSN' s 10-Year Equity to Asset Range
Min: -0.06   Max: 0.9
Current: 0.3

-0.06
0.9
F-Score: 4
Z-Score: -8.95
M-Score: -2.73
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -237.42
HNSN's Operating margin (%) is ranked lower than
52% of the 290 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.34 vs. HNSN: -237.42 )
HNSN' s 10-Year Operating margin (%) Range
Min: -531.5   Max: -70.79
Current: -237.42

-531.5
-70.79
Net-margin (%) -278.26
HNSN's Net-margin (%) is ranked lower than
52% of the 290 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.97 vs. HNSN: -278.26 )
HNSN' s 10-Year Net-margin (%) Range
Min: -499.96   Max: -75.52
Current: -278.26

-499.96
-75.52
ROE (%) -395.89
HNSN's ROE (%) is ranked lower than
54% of the 279 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.10 vs. HNSN: -395.89 )
HNSN' s 10-Year ROE (%) Range
Min: -267.8   Max: -52.02
Current: -395.89

-267.8
-52.02
ROA (%) -92.16
HNSN's ROA (%) is ranked lower than
53% of the 292 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.71 vs. HNSN: -92.16 )
HNSN' s 10-Year ROA (%) Range
Min: -252.93   Max: -24.81
Current: -92.16

-252.93
-24.81
ROC (Joel Greenblatt) (%) -372.89
HNSN's ROC (Joel Greenblatt) (%) is ranked lower than
51% of the 291 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.05 vs. HNSN: -372.89 )
HNSN' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -2411.13   Max: -152.22
Current: -372.89

-2411.13
-152.22
Revenue Growth (3Y)(%) -14.80
HNSN's Revenue Growth (3Y)(%) is ranked higher than
54% of the 259 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. HNSN: -14.80 )
HNSN' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0   Max: -10.2
Current: -14.8

EBITDA Growth (3Y)(%) -3.00
HNSN's EBITDA Growth (3Y)(%) is ranked higher than
66% of the 223 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. HNSN: -3.00 )
HNSN' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: 121.1
Current: -3

0
121.1
EPS Growth (3Y)(%) -3.50
HNSN's EPS Growth (3Y)(%) is ranked higher than
67% of the 218 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.20 vs. HNSN: -3.50 )
HNSN' s 10-Year EPS Growth (3Y)(%) Range
Min: -50   Max: 122.8
Current: -3.5

-50
122.8
» HNSN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

HNSN Guru Trades in

HNSN Guru Trades in

Q1 2014

HNSN Guru Trades in Q1 2014

George Soros 120,000 sh (New)
» More
Q2 2014

HNSN Guru Trades in Q2 2014

George Soros Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with HNSN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
George Soros 2014-06-30 Sold Out $1.19 - $2.75 $ 0.78-55%0
George Soros 2014-03-31 New Buy$1.65 - $2.59 $ 0.78-65%120000
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 13.00
HNSN's P/B is ranked higher than
53% of the 307 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.67 vs. HNSN: 13.00 )
HNSN' s 10-Year P/B Range
Min: 1.55   Max: 30.13
Current: 13

1.55
30.13
P/S 4.11
HNSN's P/S is ranked higher than
65% of the 307 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.00 vs. HNSN: 4.11 )
HNSN' s 10-Year P/S Range
Min: 2.75   Max: 224.91
Current: 4.11

2.75
224.91
Current Ratio 5.45
HNSN's Current Ratio is ranked higher than
90% of the 284 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.72 vs. HNSN: 5.45 )
HNSN' s 10-Year Current Ratio Range
Min: 1.08   Max: 26.06
Current: 5.45

1.08
26.06
Quick Ratio 4.27
HNSN's Quick Ratio is ranked higher than
89% of the 284 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. HNSN: 4.27 )
HNSN' s 10-Year Quick Ratio Range
Min: 0.8   Max: 26.06
Current: 4.27

0.8
26.06
Days Inventory 260.30
HNSN's Days Inventory is ranked higher than
53% of the 307 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 129.97 vs. HNSN: 260.30 )
HNSN' s 10-Year Days Inventory Range
Min: 65.35   Max: 288.85
Current: 260.3

65.35
288.85
Days Sales Outstanding 95.88
HNSN's Days Sales Outstanding is ranked higher than
63% of the 307 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 69.21 vs. HNSN: 95.88 )
HNSN' s 10-Year Days Sales Outstanding Range
Min: 90.6   Max: 147.99
Current: 95.88

90.6
147.99

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 13.00
HNSN's Price/Tangible Book is ranked higher than
61% of the 307 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.62 vs. HNSN: 13.00 )
HNSN' s 10-Year Price/Tangible Book Range
Min: 1.89   Max: 24.25
Current: 13

1.89
24.25
Price/Median PS Value 0.61
HNSN's Price/Median PS Value is ranked higher than
96% of the 307 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.26 vs. HNSN: 0.61 )
HNSN' s 10-Year Price/Median PS Value Range
Min: 0.46   Max: 25.53
Current: 0.61

0.46
25.53
Earnings Yield (Greenblatt) -45.70
HNSN's Earnings Yield (Greenblatt) is ranked lower than
53% of the 291 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.40 vs. HNSN: -45.70 )
HNSN' s 10-Year Earnings Yield (Greenblatt) Range
Min: -44.6   Max: 0
Current: -45.7

-44.6
0

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:H9M.Germany,
Hansen Medical, Inc., formerly known as AutoCath, Inc., was incorporated in Delaware in 2002. The Company completed its initial public offering on February 28, 2014. The Company develops, manufactures and sells medical robotics designed for accurate positioning, manipulation and stable control of catheters and catheter-based technologies. Its products include Sensei Robotic Catheter System, Magellan Robotic System, Artisan catheter, Lynx catheter, Magellan Robotic Catheter, and CoHesion 3D Visualization Module. Sensei Robotic Catheter System, or Sensei system, is designed to allow physicians to navigate flexible catheters with solid stability and control in interventional procedures within the atrial heart chambers. This system enables physicians to direct the movements of a robotic catheter like the Company's Artisan Control Catheter and Artisan Extend Control Catheter, or Artisan catheters, and Lynx Robotic Ablation Catheter, or Lynx catheter, to an anatomical location. The Sensei system is comprised of two modules: a physician control console and a patient-side module that can be connected to procedure tables. The control console can be located inside the Electro-Physiology Laboratory, or EP lab, and close to the patient or outside the EP lab in a separate location shielded from radiation. The Company's Magellan Robotic System is a peripheral vascular interventional platform that, used in combination with the Magellan Robotic Catheters, has the potential to provide endovascular specialists with vessel navigation, catheter stability during the manual delivery and placement of therapeutic devices, reduced procedural radiation exposure and fatigue, and precise robotic control of distal catheter tips. Magellan Robotic System is comprised of two modules: a physician control console and a patient-side robotic arm that can be connected to procedure tables. The Artisan catheter is a disposable catheter and guide catheter assembly that consists of a telescoping set of control catheters that are integrated to provide the desired motion of the tip of a diagnostic or therapeutic catheter that is inserted through the center lumen of the Artisan catheter. This is designed to accurately control the movement of a third party catheter chosen by the physician. CoHesion 3D Visualization Module, or CoHesion Module, is a software interface between Sensei system and the St. Jude Medical EnSite System for EP procedures. It is designed to provide physicians with 3D visualization to augment their ability to move a catheter throughout the atria, as well as increase control over placement of the catheter in specific locations. The Company markets, sells and supports its products in the United States through a direct sales force of regional sales employees, supported by clinical account managers who provide training, clinical support and other services to customers. Outside the United States, in the European Union, it uses a combination of a direct sales
» More Articles for HNSN

Headlines

Articles On GuruFocus.com
Hansen Medical Announces Expanded Protocol for the ARTISAN AF IDE Study Feb 05 2015 
Hansen Medical Announces Completion of First Clinical Procedure With the Magellan(TM) Robotic System Jan 27 2015 
Hansen Medical Announces Completion of World's First Intravascular Robot-Assisted IVC Filter Retriev Jan 22 2015 
Hansen Medical Announces Key Developments in Global Expansion Strategy Dec 19 2014 
Hansen Medical Announces Completion of First Robotic Prostatic Artery Embolization Procedure (PAE) i Nov 20 2014 
Hansen Medical Announces 2014 Release of Third Quarter Earnings Results Nov 04 2014 
Hansen Medical Announces Global Launch of the Sensei X2(R) Robotic System Oct 30 2014 
Hansen Medical Announces Completion of First Robot-Assisted Uterine Fibroid Embolization Procedure i Oct 21 2014 
5-year lows: Layne Christensen Co, Hansen Medical Inc, API Technologies Corp, and Female Health Co. Jul 27 2014 
Hansen Medical possibly the next Intuitive Surgical Jul 27 2011 

More From Other Websites
Hansen Medical(R) Announces Completion of First Clinical Procedures With the Magellan(TM) Robotic... Feb 26 2015
Hansen Medical Reports Fourth Quarter and Full-Year 2014 Results Feb 23 2015
WSA Medical Spotlight Feb 17 2015
Hansen Medical to Highlight Magellan(TM) Robotic Embolization Procedures at 40th Annual Society of... Feb 11 2015
Hansen Medical Announces Expanded Protocol for the ARTISAN AF IDE Study Feb 05 2015
Hansen Medical Announces Expanded Protocol for the ARTISAN AF IDE Study Feb 05 2015
Study Finds Magellan(TM) Robotic System From Hansen Medical Reduces Radiation to Operator by Over... Feb 03 2015
IDEXX Tops Q4 Earnings, Lags Revenues; Tweaks 2015 View - Analyst Blog Feb 02 2015
Can the Rally in Hansen Medical (HNSN) Shares Continue? - Tale of the Tape Jan 29 2015
Hansen Medical to Showcase Magellan(TM) Robotic System at 2015 International Aortic Summit (IAS) Jan 29 2015
Hansen Medical to Showcase Magellan(TM) Robotic System at 2015 International Aortic Summit (IAS) Jan 29 2015
Hansen Medical Announces Completion of First Clinical Procedure With the Magellan(TM) Robotic System... Jan 27 2015
Hansen Medical to Showcase New Magellan(TM) 6Fr Robotic Catheter at 27th Annual ISET Meeting Jan 22 2015
Hansen Medical Announces Completion of World's First Intravascular Robot-Assisted IVC Filter... Jan 22 2015
Hansen Medical Announces Completion of World's First Intravascular Robot-Assisted IVC Filter... Jan 22 2015
Hansen Medical to Showcase New Magellan(TM) 6Fr Robotic Catheter at 27th Annual ISET Meeting Jan 20 2015
Is Myriad Genetics (MYGN) Worth Adding to Your Portfolio? - Analyst Blog Jan 16 2015
Cyberonics (CYBX) Now a Buy: Are You Considering? - Analyst Blog Jan 15 2015
Hansen Medical Announces Key Developments in Global Expansion Strategy Dec 19 2014
Hansen Medical Announces Key Developments in Global Expansion Strategy Dec 19 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK